Skip to main content

What the FDA labels say about taking them together

Furosemide and meclofenamate

Meclofenamate's FDA label of April 15, 2026 names furosemide in its drug interactions section; the furosemide labels PlainMeds reads (4) do not name meclofenamate. The meclofenamate label: “Furosemide Clinical studies, as well as post-marketing observations, have shown that meclofenamate sodium can reduce the natriuretic effect-of furosemide and thiazides in some patients.”

Check it at the source: the furosemide FDA label on DailyMed (effective September 30, 2025, Validus Pharmaceuticals LLC); the meclofenamate FDA label on DailyMed (effective April 15, 2026, Mylan Pharmaceuticals Inc.).

What does the furosemide label say about meclofenamate?

Furosemide's label (effective September 30, 2025) and its 3 other brand-application labels do not name meclofenamate in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Lasix), Validus Pharmaceuticals LLC, effective September 30, 2025 (SPL set 2c9b4d8f-0770-482d-a9e6-9c616a440b1a), via openFDA; the full label on DailyMed

What does the meclofenamate label say about furosemide?

Meclofenamate label, drug interactions

Furosemide Clinical studies, as well as post-marketing observations, have shown that meclofenamate sodium can reduce the natriuretic effect-of furosemide and thiazides in some patients.

Source: FDA drug label (Meclofenamate Sodium), Mylan Pharmaceuticals Inc., effective April 15, 2026 (SPL set 96f19af4-de8f-4fd7-90d8-55fe6ebdd81d), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

52Furosemide generic labelers
1Meclofenamate generic labelers
FurosemideMeclofenamate
Labeled forHeart failure, High blood pressure, Edema (fluid retention)Fever, Pain, Rheumatoid arthritis, Osteoarthritis
Boxed warningNoYes
Pharmacy cost (NADAC)$0.490 per mL 20 mg/2 mL vialn/a
Shortage nowIn shortageNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?